A prospective, single arm cohort study published in November 2019 from the journal of Postgraduate Medicine evaluated the use of cannabinoids as an alternative therapy to opioids.
Eligibility criteria included age between 30 to 50 years old, has moderate to severe chronic pain over 3 years, and has been stable on opioids for 1 year.
Most participants (>95%) elected to use 30mg CBD daily over the time of the study.
Over half of the patients with chronic pain (53%) reduced or eliminated the use of opioids within 8 weeks of adding CBD-rich hemp extract to their regimens. Almost all CBD users (94%) reported quality of life improvements, specifically in regards to pain and quality of sleep.
